Peptide APIs
-
Glucagon
Glucagon is a natural peptide hormone used as an emergency treatment for severe hypoglycemia and studied for its role in metabolic regulation, weight loss, and digestive diagnostics.
-
Motixafortide
Motixafortide is a synthetic CXCR4 antagonist peptide developed to mobilize hematopoietic stem cells (HSCs) for autologous transplantation and is also being studied in oncology and immunotherapy.
-
Glepaglutide
Glepaglutide is a long-acting GLP-2 analog developed for the treatment of short bowel syndrome (SBS). It enhances intestinal absorption and growth, helping patients reduce dependence on parenteral nutrition.
-
Elamipretide
Elamipretide is a mitochondria-targeted tetrapeptide developed to treat diseases caused by mitochondrial dysfunction, including primary mitochondrial myopathy, Barth syndrome, and heart failure.
-
Pegcetacoplan
Pegcetacoplan is a pegylated cyclic peptide that acts as a targeted C3 complement inhibitor, developed for the treatment of complement-mediated diseases such as paroxysmal nocturnal hemoglobinuria (PNH) and geographic atrophy (GA) in age-related macular degeneration.
-
Palopegteriparatide
Palopegteriparatide is a long-acting parathyroid hormone receptor agonist (PTH1R agonist), developed for the treatment of chronic hypoparathyroidism. It is a pegylated analog of PTH (1-34) designed to provide sustained calcium regulation with once-weekly dosing.
-
GHRP-6
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that acts as a growth hormone secretagogue, stimulating the body’s natural release of growth hormone (GH) by activating the GHSR-1a receptor.
API Features :
Purity ≥99%
Manufactured via solid-phase peptide synthesis (SPPS)
Supplied for R&D and commercial use
GHRP-6 is a versatile research peptide for metabolic support, muscle regeneration, and hormonal modulation.
-
GHRP-2
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide and potent growth hormone secretagogue, designed to stimulate the natural release of growth hormone (GH) by activating the GHSR-1a receptor in the hypothalamus and pituitary.
API Features:
Purity ≥99%
Available for R&D and commercial supply, with full QC documentation
GHRP-2 is a valuable research peptide in the fields of endocrinology, regenerative medicine, and age-related therapies.
-
Hexarelin
Hexarelin is a synthetic growth hormone secretagogue peptide (GHS) and potent GHSR-1a agonist, developed to stimulate endogenous growth hormone (GH) release. It belongs to the ghrelin mimetic family and is composed of six amino acids (a hexapeptide), offering enhanced metabolic stability and stronger GH-releasing effects compared to earlier analogs like GHRP-6.
API Features :
Purity ≥ 99%
Produced via solid-phase peptide synthesis (SPPS)
GMP-like standards, low endotoxin and solvent residues
Flexible supply: R&D to commercial scale
-
Melanotan II
API Features:
High purity ≥ 99%
Synthesized via solid-phase peptide synthesis (SPPS)
Low endotoxin, low residual solvents
Available in R&D to commercial scale -
Melanotan 1
Melanotan 1 API is produced using solid phase peptide synthesis (SPPS) technology under strict GMP-like quality control conditions.
-
High purity ≥99%
-
Solid-phase peptide synthesis (SPPS)
-
GMP-like manufacturing standards
-
Full documentation: COA, MSDS, stability data
-
Scalable supply: R&D to commercial levels
-
-
MOTS-C
MOTS-C API is produced under strict GMP-like conditions using solid phase peptide synthesis (SPPS) technology to ensure its high quality, high purity and high stability for research and therapeutic use.
Product Features:Purity ≥ 99% (confirmed by HPLC and LC-MS),
Low endotoxin and residual solvent content,
Produced in accordance with ICH Q7 and GMP-like protocols,
Can achieve large-scale production, from milligram-level R&D batches to gram-level and kilogram-level commercial supply.